Learn more about our policy experts.

Media Contacts

Angela Bradbery, Director of Communications
w. (202) 588-7741
c. (202) 503-6768
abradbery@citizen.org, Twitter

Don Owens, Deputy Director of Communications
w. (202) 588-7767

Karilyn Gower, Press Officer
w. (202) 588-7779

David Rosen, Press Officer, Regulatory Affairs
w. (202) 588-7742

Nicholas Florko, Communications Officer, Global Trade Watch
w. (202) 454-5108

Other Important Links

Press Release Database
Citizen Vox blog
Texas Vox blog
Consumer Law and Policy blog
Energy Vox blog
Eyes on Trade blog

Follow us on Twitter


Dec. 7, 2010 
FDA Must Not Approve Another Dangerous Weight Loss Drug

Statement of Dr. Sidney Wolfe, Director, Public Citizen’s Health Research Group

 An advisory committee for the Food and Drug Administration (FDA) will weigh approval of another weight loss drug today – and the agency must reject it.

 The diet pill Contrave is the latest in a long line of dangerous and, ultimately, failed weight loss drugs. All of the following drugs, once approved for weight reduction, had severe cardiovascular side effects and were later either banned or de-listed for weight loss: thyroid hormone, amphetamine, fenfluramine/dexfenfluramine (also known as fen-phen), phenlylpropanolamine (PPA), ephedra and sibutramine (also known as Meridia).

 Contrave, manufactured by Orexigen Therapeutics, has shown to worsen key cardiovascular risk factors, including increased blood pressure, heart rate and palpitations, which nullify the cardiovascular benefit of weight loss in these patients.

 Additionally, the drug is expected to cause seizures. With millions of new people likely to receive this drug, if approved, this could represent an enormous burden of new disease.

 To further increase the cardiovascular and other health risks of these obese patients – who are already vulnerable to cardiovascular disease – is unacceptable. The FDA advisory committee and the agency as a whole should reject the approval of Contrave. The fact that one of its ingredients, bupropion, was previously known to cause increased blood pressure – an unequivocal risk factor for heart attacks and strokes – makes the attempt to study and approve this drug unethical.

 To read the full remarks presented to the FDA advisory committee on Contrave, visit: http://www.citizen.org/hrg1922.

Public Citizen is a national, nonprofit consumer advocacy organization based in Washington, D.C. For more information, please visit www.citizen.org.

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.


To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.